BMC Cancer

Papers
(The median citation count of BMC Cancer is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Lnc-SELPLG-2:1 enhanced osteosarcoma oncogenesis via hsa-miR-10a-5p and the BTRC cascade253
Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification143
Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer119
Chemotherapy dose per kilogram lean body mass increased dose-limiting toxicity event in male head and neck cancer with taxane and platinum-based induction therapy116
Low-grade inflammation in survivors of childhood cancer and testicular cancer and its association with hypogonadism and metabolic risk factors110
Exposure–response analyses of cabozantinib in patients with metastatic renal cell cancer90
The gene expression profile and cell of origin of canine peripheral T-cell lymphoma89
Changing patterns of nasopharyngeal carcinoma incidence in Hong Kong: a 30-year analysis and future projections86
Effects of neoadjuvant radiochemotherapy for anorectal function in locally advanced rectal cancer patients: a study protocol for a prospective, observational, controlled, multicentre study80
Association of Radiochemotherapy to Immunotherapy in unresectable locally advanced Oesophageal carciNoma—randomized phase 2 trial ARION UCGI 33/PRODIGE 67: the study protocol76
Development and psychometric properties of Health-Promoting Lifestyle Scale in Colorectal Cancer Survivors (HPLS-CRCS): a mixed-method study71
ESR1 PvuII polymorphism: from risk factor to prognostic and predictive factor of the success of primary systemic therapy in advanced breast cancer69
Single-copy Snail upregulation causes partial epithelial-mesenchymal transition in colon cancer cells66
Network Evolution Model-based prediction of tumor mutation burden from radiomic-clinical features in endometrial cancers66
Adult breast, lung, pancreatic, upper and lower gastrointestinal cancer patients with hospitalized venous thromboembolism in the national French hospital discharge database65
Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer61
Association of oxaliplatin-containing adjuvant duration with post-treatment fall-related injury and fracture in patients with stage III colon cancer: a population-based retrospective cohort study60
Rapid and label-free detection of gastrointestinal stromal tumor via a combination of two-photon microscopy and imaging analysis60
Exploring optimal administration timing of pegylated recombinant human granulocyte colony-stimulating factor for chemotherapy-induced neutropenia in early breast cancer treated with pharmorubicin and 58
Results from a real-world study: a novel glycosyltransferase risk score for prognosis, tumor microenvironment phenotypes and immunotherapy in bladder cancer58
Predicting biochemical-recurrence-free survival using a three-metabolic-gene risk score model in prostate cancer patients55
The change rate in serum nitric oxide may affect lenvatinib therapy in hepatocellular carcinoma54
Image-guided navigation for locally advanced primary and locally recurrent rectal cancer: evaluation of its early cost-effectiveness52
Deep learning based on intratumoral heterogeneity predicts histopathologic grade of hepatocellular carcinoma52
Increased use of diagnostic CT imaging increases the detection of stage IA lung cancer: pathways and patient characteristics49
TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer48
Favorable locoregional control in clinically node-negative hormone-receptor positive breast cancer with low 21-gene recurrence scores: a single-institution study with 10-year follow-up48
NTRK fusion promotes tumor migration and invasion through epithelial–mesenchymal transition and closely interacts with ECM1 and NOVA148
Correlation between overall survival and quality of life in colon cancer patients with chemotherapy48
Realizing the promise of machine learning in precision oncology: expert perspectives on opportunities and challenges47
Gross recurrent laryngeal nerve invasion by extranodal extension in thyroid carcinoma47
The impact of curative cancer treatment on sexual health – clinical results from the EORTC QLQ-SH22 validation study46
Unraveling the causal links and novel molecular classification of Crohn’s disease in breast Cancer: a two-sample mendelian randomization and transcriptome analysis with prognostic modeling46
Integrated analysis of single-cell and bulk transcriptomics reveals cellular subtypes and molecular features associated with osteosarcoma prognosis46
Prospective clinical evidence from over 1,000 pan-cancer patients: a complement to fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting46
Long noncoding RNA TMPO-AS1 accelerates glycolysis by regulating the miR-1270/PKM2 axis in colorectal cancer46
Neoadjuvant immune checkpoint inhibitor reduced recurrence in operable NSCLC patients with pathological complete response: a retrospective analysis45
The mortality rate of people with cancer judged to have a limited life expectancy by physicians performing work disability assessments in the Netherlands: a retrospective cohort study44
Azacytidine treatment affects the methylation pattern of genomic and cell-free DNA in uveal melanoma cell lines44
Immunohistochemical analysis of Tn antigen expression in colorectal adenocarcinoma and precursor lesions43
Efficacy and safety of PD-1/PD-L1 inhibitors in patients with Merkel Cell Carcinoma: a systematic review and Meta-analysis43
Analysis of characteristics of peripheral blood lymphocytes in endometrial carcinoma: a single-center study based on five-year clinical data43
Multicentre, randomised, open-label, parallel-group, clinical phase II study to evaluate immunonutrition in improving efficacy of immunotherapy in patients with metastatic non-small cell lung cancer, 43
IMProving care After inherited Cancer Testing (IMPACT) study: protocol of a randomized trial evaluating the efficacy of two interventions designed to improve cancer risk management and family communic42
Impact of perioperative decreased serum albumin level on anastomotic leakage in esophageal squamous cell carcinoma patients treated with neoadjuvant chemotherapy followed by minimally invasive esophag42
Antibiotic use during radical surgery in stage I-III colorectal cancer: correlation with outcomes?41
Tertiary lymphoid structures associate with improved survival in early oral tongue cancer40
A metabolome-wide case-control study of african american breast cancer patients40
Factors influencing clinical decision-making and health-related quality of life changes in colorectal cancer patients receiving targeted therapy: a multicenter study in China39
Survival impact and risk factors of skeletal muscle loss during first-line EGFR-TKIs therapy in advanced lung adenocarcinoma patients39
Development and validation of a nomogram for predicting sever cancer-related fatigue in patients with cervical cancer39
Lactate receptor GPR81 drives breast cancer growth and invasiveness through regulation of ECM properties and Notch ligand DLL438
Dosimetric effects of bladder volume changes in MR-guided radiotherapy for cervical cancer38
Construction and validation of a gene signature related to bladder urothelial carcinoma based on immune gene analysis38
Pseudocapsule thickness is positively associated with prognosis in patients with clear cell renal cell carcinoma38
Prognostic value of tumor-infiltrating CD163+macrophage in patients with metastatic gastric cancer undergoing multidisciplinary treatment37
Association of portfolio diet score with breast cancer risk: insights from a case-control analysis37
High SNHG expression may predict a poor lung cancer prognosis based on a meta-analysis37
Assessing the performance of QLQ-C30 in predicting all-cause mortality in community cancer patients37
The efficacy of human epidermal growth factor receptor 2 (HER2) blockade switching mode in refractory patients with HER2-positive metastatic breast cancer: a phase II, multicenter, single-arm study (S37
Mismatch repair, p53, and L1 cell adhesion molecule status influence the response to chemotherapy in advanced and recurrent endometrial cancer36
Alpha-1 antitrypsin deficiency and risk of lung cancer in never-smokers: a multicentre case–control study36
Rationale and design of APOLLO: a personalized rehAbilitation PrOgram in aLLOgeneic bone marrow transplantation36
MTF1 genetic variants are associated with lung cancer risk in the Chinese Han population36
Exploring the role of ELOVLs family in lung adenocarcinoma based on bioinformatic analysis and experimental validation36
Baseline C-reactive protein predicts efficacy of the first-line immune checkpoint inhibitors plus chemotherapy in advanced lung squamous cell carcinoma: a retrospective, multicenter study35
MiR-214-3p targets Ras-related protein 14 (RAB14) to inhibit cellular migration and invasion in esophageal Cancer cells35
Prognostic factors for resected invasive mucinous lung adenocarcinoma: a systematic review and meta-analysis35
Adipogenesis biomarkers as the independent predictive factors for breast cancer recurrence: a systematic review and meta-analysis35
Ultrasound-based radiomics machine learning models for diagnosing cervical lymph node metastasis in patients with non-small cell lung cancer: a multicentre study35
Integration of graph neural networks and transcriptomics analysis identify key pathways and gene signature for immunotherapy response and prognosis of skin melanoma34
Apatinib combined with temozolomide in diffuse midline glioma: a novel and effective therapy34
Setting the international research agenda for sarcomas with patients and carers: results of phase II of the Sarcoma Patient Advocacy Global Network (SPAGN) priority setting partnership34
Understanding referral of patients with cancer in rural Ethiopia: a qualitative study34
Estrogen-related genes for thyroid cancer prognosis, immune infiltration, staging, and drug sensitivity34
Combined inflammation-related biomarkers and clinicopathological features for the prognosis of stage II/III colorectal cancer by machine learning34
Impact of lenalidomide consolidation on health-related quality of life in chronic lymphocytic leukemia: ancillary study of the phase III CLL6-RESIDUUM trial34
Exercise-based dysphagia rehabilitation for adults with oesophageal cancer: a systematic review34
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients34
Evaluating the prognostic significance of p53 and TP53 mutations in HPV-negative hypopharyngeal carcinoma patients: a 5-year follow-up retrospective study34
Added value of pretreatment CT-based Node-RADS score for predicting survival outcome of locally advanced gastric cancer: compared with clinical N stage34
Pan-cancer analysis identifies SPEN mutation as a predictive biomarker with the efficacy of immunotherapy34
Alcohol consumption and cancer incidence in women: interaction with smoking, body mass index and menopausal hormone therapy33
Colorectal cancer survival among Ministry of National Guard-Health Affairs (MNG-HA) population 2009–2017: retrospective study33
EXOSC5: a novel biomarker for poor prognosis in lung adenocarcinoma33
Effects of sleep disturbances and circadian rhythms modifications on cognition in breast cancer women before and after adjuvant chemotherapy: the ICANSLEEP-1 protocol33
Development of a novel predictive model for lymph node metastasis in patients with endometrial endometrioid carcinoma33
Muscle strength is associated with fracture risk obtained by fracture risk assessment tool (FRAX) in women with breast cancer33
Relationship between SUVmax on 18F-FDG PET and PD-L1 expression in liver metastasis lesions after colon radical operation33
Association between psychiatric disorders and glioma risk: evidence from Mendelian randomization analysis33
Safety and feasibility of liver resection including major hepatectomy for geriatric patients with hepatocellular carcinoma: a retrospective observational study33
Programmed cell death ligand 1 measurement study in granulocyte colony-stimulating factor-producing lung cancer: an observational study33
Fedratinib combined with ropeginterferon alfa-2b in patients with myelofibrosis (FEDORA): study protocol for a multicentre, open-label, Bayesian phase II trial33
The relationship between dairy products intake and breast cancer incidence: a meta-analysis of observational studies32
“It's very important that you measure throughout that journey…”: patient perspectives towards quality-of-life data collection following haematopoietic cell transplant32
Improved urine DNA methylation panel for early bladder cancer detection32
Camrelizumab combined with apatinib plus irinotecan as a second-line treatment in advanced or metastatic esophageal squamous cell carcinoma patients32
Glycometabolism and lipid metabolism related genes predict the prognosis of endometrial carcinoma and their effects on tumor cells32
Assessing health-related quality of life among cancer survivors during systemic and radiation therapy in Bangladesh: a cancer-specific exploration32
L-arginine dependence of breast cancer – molecular subtypes matter.32
Physician-patient communication of costs and financial burden of cancer and its treatment: a systematic review of clinical guidelines32
TFEB, SIRT1, CARM1, Beclin-1 expression and PITX2 methylation in breast cancer chemoresistance: a retrospective study31
Exosomal microRNA-107 reverses chemotherapeutic drug resistance of gastric cancer cells through HMGA2/mTOR/P-gp pathway31
Hsa_circ_0004872 alleviates meningioma progression by sponging miR-190a-3p/PTEN signaling31
The role of the bacterial microbiome in the treatment of cancer31
Cancer risk in persons with new-onset anaemia: a population-based cohort study in Denmark31
Associations of the circulating levels of cytokines with the risk of myeloproliferative neoplasms: a bidirectional mendelian-randomization study30
Gene mutation in cancer patients with diabetes: a real-world retrospective cohort study30
A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC30
Prognostic value of IDH2R140 and IDH2R172 mutations in patients with acute myeloid leukemia: a systematic review and meta-analysis30
microRNA-622 upregulates cell cycle process by targeting FOLR2 to promote CRC proliferation30
Differential effects of HIF2α antagonist and HIF2α silencing in renal cancer and sensitivity to repurposed drugs30
Perioperative outcomes and continence following robotic-assisted radical cystectomy with mainz pouch II urinary diversion in patients with bladder cancer30
Clinicopathologic and prognosis of 30 patients with FH-deficient renal cell carcinoma: a single-center retrospective study30
An in-frame deletion mutation in MLH1 drives Lynch syndrome-associated colorectal cancer30
Effect of PR status on the prognosis of advanced ER-high HER2-negative breast cancer patients receiving CDK4/6 inhibitor combined with endocrine as first-line therapy30
Cancer-associated fibroblasts drive colorectal cancer cell progression through exosomal miR-20a-5p-mediated targeting of PTEN and stimulating interleukin-6 production29
Real-world patient-reported outcomes and physician satisfaction with poly (ADP-ribose) polymerase inhibitors versus chemotherapy in patients with germline BRCA1/2-mutated human epidermal growth factor29
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy with or without nimotuzumab in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study29
MicroRNA-21 promotes head and neck squamous cell carcinoma (HNSCC) induced transition of bone marrow mesenchymal stem cells to cancer-associated fibroblasts29
A novel nomogram based on cell cycle-related genes for predicting overall survival in early-onset colorectal cancer29
Patient reported outcomes following whole brain radiotherapy in patients with brain metastases in NSIA-LUTH Cancer Center29
Integrative analysis of the prognostic value and immune microenvironment of mitophagy-related signature for multiple myeloma29
Single-cell sequencing unveils the transcriptomic landscape of castration-resistant prostate cancer-associated fibroblasts and their association with prognosis and immunotherapy response29
Identification of alternative lengthening of telomeres-related genes prognosis model in hepatocellular carcinoma29
Comparing biweekly single-dose actinomycin D with multiday methotrexate therapy for low-risk gestational trophoblastic neoplasia (FIGO Score 0–4): study protocol for a prospective, multicentre, random29
Ten-year follow-up of atypical small acinar hyperplasia cases diagnosed by initial prostate biopsy28
The value of diffusion kurtosis imaging and intravoxel incoherent motion quantitative parameters in predicting synchronous distant metastasis of rectal cancer28
Prediction models of breast cancer molecular subtypes based on multimodal ultrasound and clinical features28
Integrated analysis of the prognostic and oncogenic roles of OPN3 in human cancers28
Short-term impact of delayed surgical treatment on the prognosis of patients with T1bN1-stage PTC: a retrospective cohort study28
Female breast cancer incidence predisposing risk factors identification using nationwide big data: a matched nested case-control study in Taiwan28
A high CD8 to FOXP3 ratio in the tumor stroma and expression of PTEN in tumor cells are associated with improved survival in non-metastatic triple-negative breast carcinoma27
PIK3R3, a regulatory subunit of PI3K, modulates ovarian cancer stem cells and ovarian cancer development and progression by integrative analysis27
Whole-body CT scanning radiation improves the immune microenvironment of tumor tissues to enhance the antitumor effect of ICI27
Regulation of KLRC and Ceacam gene expression by miR-141 supports cell proliferation and metastasis in cervical cancer cells27
Targeting INF2 with DiosMetin 7-O-β-D-Glucuronide: a new stratagem for colorectal cancer therapy27
AC010883.5 promotes cell proliferation, invasion, migration, and epithelial-to-mesenchymal transition in cervical cancer by modulating the MAPK signaling pathway27
Anti-PD-1 combined sorafenib versus anti-PD-1 alone in the treatment of advanced hepatocellular cell carcinoma: a propensity score-matching study27
Predictive model for long-term weight recovery after gastrectomy for gastric cancer: an introduction to a web calculator27
Comparative analysis of efficacy and safety between D-TACE + HAIC + lenvatinib and D-TACE + lenvatinib in the treatment of unresectable massive hepatocellular carcinoma27
Efficacy and safety analysis of TACE + Donafenib + Toripalimab versus TACE + Sorafenib in the treatment of unresectable hepatocellular carcinoma: a retrospective study27
Baseline serum tumor markers predict the survival of patients with advanced non-small cell lung cancer receiving first-line immunotherapy: a multicenter retrospective study27
The levels of plasma MiR-9 and MiR-106a are associated with the development of peritoneal carcinomatosis in patients with gastric cancer26
Underdiagnosis of iron deficiency anemia among patients with colorectal cancer: an examination of electronic medical records26
Atovaquone inhibits colorectal cancer metastasis by regulating PDGFRβ/NF-κB signaling pathway26
Circ_0064288 acts as an oncogene of hepatocellular carcinoma cells by inhibiting miR-335-5p expression and promoting ROCK1 expression26
Deep learning-based characterization of pathological subtypes in lung invasive adenocarcinoma utilizing 18F-deoxyglucose positron emission tomography imaging26
Effectiveness of educational intervention on women’s participation to cervical cancer screening: a quasi-experimental study based on PEN-3 model26
Interplay of disulfidptosis and the tumor microenvironment across cancers: implications for prognosis and therapeutic responses26
The association between organised colorectal cancer screening strategies and reduction of its related mortality: a systematic review and meta-analysis26
Sex-disaggregated analysis of breast cancer prevalence in Sierra Leone26
Prospective comparison of early interim 18F-FDG-PET with 18F-FLT-PET for predicting treatment response and survival in metastatic breast cancer26
Clinical outcomes of advanced non-small cell lung cancer patients harboring distinct subtypes of EGFR mutations and receiving first-line tyrosine kinase inhibitors: brain metastasis and de novo T790M 26
A protocol for a multidisciplinary early intervention during chemotherapy to improve dietary management behavior in breast cancer patients: a two-arm, single-center randomized controlled trial26
Survival benefit of adjuvant TACE for patients with hepatocellular carcinoma and child-pugh B7 or B8 after hepatectomy25
Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlle25
Accumulating evidence from meta-analyses of prognostic studies on oral cancer: towards biomarker-driven patient selection25
Oral cavity and oropharyngeal carcinoma disparities in age and survival in Indigenous and non-Indigenous populations of Queensland25
Therapeutic and immunomodulatory effects of Bojungikki-tang on cancer: a scoping review25
A case-control study of a combination of single nucleotide polymorphisms and clinical parameters to predict clinically relevant toxicity associated with fluoropyrimidine and platinum-based chemotherap25
Pembrolizumab plus epacadostat in patients with recurrent/metastatic head and neck squamous cell carcinoma (KEYNOTE-669/ECHO-304): a phase 3, randomized, open-label study25
MLXIPL promotes the migration, invasion, and glycolysis of hepatocellular carcinoma cells by phosphorylation of mTOR25
Association of HLA-A*02:01 type with efficacy and toxicity of immune checkpoint inhibitor therapy in melanoma patients: a retrospective cohort study25
Secular trends of morbidity and mortality of prostate, bladder, and kidney cancers in China, 1990 to 2019 and their predictions to 203025
Clinical benefits of enhanced 3D-NEVERview sequence in MRI simulation for nasopharyngeal carcinoma patients received radiotherapy25
Optimal treatment strategies for hepatoid adenocarcinoma of the lung: insights from a comprehensive analysis25
Alpha-fetoprotein predicts the treatment efficacy of immune checkpoint inhibitors for gastric cancer patients25
HTR1D regulates the PI3K/Akt signaling pathway to impact hepatocellular carcinoma development and resistance to sorafenib25
Malnutrition and visceral obesity predicted adverse short-term and long-term outcomes in patients undergoing proctectomy for rectal cancer25
The role of AKR1 family in tamoxifen resistant invasive lobular breast cancer based on data mining25
Novel model integrating computed tomography-based image markers with genetic markers for discriminating radiation pneumonitis in patients with unresectable stage III non-small cell lung cancer receivi25
A survival comparison of gastric mucin-producing adenocarcinoma to conventional adenocarcinoma: a SEER database analysis24
Dynamic nomograms combining N classification with ratio-based nodal classifications to predict long-term survival for patients with lung adenocarcinoma after surgery: a SEER population-based study24
System-wide identification of novel de-ubiquitination targets for USP10 in gastric cancer metastasis through multi-omics screening24
Most oncological pancreas resections must consider the mesopancreas24
High-throughput methylation sequencing reveals novel biomarkers for the early detection of renal cell carcinoma24
TUBA1C is a potential new prognostic biomarker and promotes bladder urothelial carcinoma progression by regulating the cell cycle24
Senescence-specific molecular subtypes stratify the hallmarks of the tumor microenvironment and guide precision medicine in bladder cancer24
Correction: Circulating Tumor cells and multiple indicators combined to identify the risk of poorer prognosis in patients with resected non-small cell lung cancer24
Gut microbiome and its role in colorectal cancer24
Development of a clinical-molecular prediction model for central lymph node metastasis in cN0 stage papillary thyroid microcarcinoma: a retrospective study24
Association between preoperative anxiety states and postoperative complications in patients with esophageal cancer and COPD: a retrospective cohort study24
Establishing a whole blood CD4+ T cell immunity measurement to predict response to anti-PD-124
Prediction of esophageal cancer risk based on genetic variants and environmental risk factors in Chinese population24
The Tie2 antagonist rebastinib reduces ovarian cancer growth in a syngeneic murine model24
A new risk model based on a 11-m6A-related lncRNA signature for predicting prognosis and monitoring immunotherapy for gastric cancer24
Molecular profiling reveals novel therapeutic targets and clonal evolution in ovarian clear cell carcinoma24
Nomogram model for predicting the long-term prognosis of cervical cancer patients: a population-based study in Mato Grosso, Brazil24
Characterization and comparison of human glioblastoma models24
Analyses of quality of life in cancer drug trials - a review of measurements and analytical choices in post-reimbursement studies24
A clinical model to predict brain metastases in resected early-stage non-small cell lung cancer24
A multicenter prospective cohort study to evaluate feasibility of radio-frequency identification surgical guidance for nonpalpable breast lesions: design and rationale of the RFID Localizer 1 Trial23
High-risk HPV infection-associated hypermethylated genes in oropharyngeal squamous cell carcinomas23
Aiming for survival: a qualitative single case study of support for family members across the care process in outpatient colorectal cancer care23
Circulating tumor cells from melanoma patients show phenotypic plasticity and metastatic potential in xenograft NOD.CB17 mice23
Association between NDRG1 protein expression and aggressive features of breast cancer: a systematic review and meta-analysis23
FLT3LG modulates the infiltration of immune cells and enhances the efficacy of anti-PD-1 therapy in lung adenocarcinoma23
Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study23
Correlation analysis of DLG5 and PD-L1 expression in triple-negative breast cancer23
Expressional variations of Kaiso: an association with pathological characteristics and field cancerization of OSCC23
Identification of CEACAM5 as a stemness-related inhibitory immune checkpoint in pancreatic cancer23
A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma23
Association between triglyceride-glucose index and hypertension in adults with cancer from NHANES 2005–2018: a cross-sectional study23
Elevated LILRB1 expression predicts poor prognosis and is associated with tumor immune infiltration in patients with glioma23
Hepatitis B and C virus infection and risk of multiple myeloma: a systematic review and meta-analysis23
Dual-region MRI radiomic analysis indicates increased risk in high-risk breast lesions: bridging intratumoral and peritumoral radiomics for precision decision-making23
Integrated multi-omics analyses revealed the association between rheumatoid arthritis and colorectal cancer: MYO9A as a shared gene signature and an immune-related therapeutic target23
Effects of preoperative albumin-to-globulin ratio on overall survival and quality of life in esophageal cell squamous carcinoma patients: a prospective cohort study23
Anti-cancer properties of chitosan /Lactobacillus acidophilus secretome nanoparticle on signaling pathways of colorectal cancer in colon adenocarcinoma (Caco-2) cell line22
Prognostic value of serum inflammatory markers in patients with esophageal squamous cell carcinoma undergoing surgery: a two-center retrospective cohort study22
Potential of miR-181a-5p and miR-630 as clinical biomarkers in NSCLC22
Predicting response to immunotherapy plus chemotherapy in patients with esophageal squamous cell carcinoma using non-invasive Radiomic biomarkers22
RETRACTED ARTICLE: LRPPRC regulates malignant behaviors, protects mitochondrial homeostasis, mitochondrial function in osteosarcoma and derived cancer stem-like cells22
The clinicopathological significance of thymic epithelial markers expression in thymoma and thymic carcinoma22
Exploring educational disparities in breast cancer dynamics: a comprehensive analysis of incidence, death within 5 years of diagnosis, and mortality in the Belgian context22
Treatment patterns of targeted and nontargeted therapies and survival effects in patients with locally advanced head and neck cancer in Taiwan22
Dose escalation with stereotactic body radiotherapy for cervical cancer treatment22
The prognostic impact of macroscopic serosal change on resectable advanced gastric cancer22
Circulating MiR-1290 as a potential diagnostic and disease monitoring biomarker of human gastrointestinal tumors22
Preoperative IL-8 levels as prognostic indicators of overall survival: an extended follow-up in a prospective cohort with colorectal liver metastases22
Deciphering a proliferation-essential gene signature based on CRISPR-Cas9 screening to predict prognosis and characterize the immune microenvironment in HNSCC22
LINC00958 promotes bladder cancer carcinogenesis by targeting miR-490-3p and AURKA22
The prognostic value of the advanced lung cancer inflammation index in patients with gastrointestinal malignancy22
Tumor necrosis factor-α-inducible protein 8-like protein 3 (TIPE3): a novel prognostic factor in colorectal cancer22
NEXUS trial: a multicenter phase II clinical study evaluating the efficacy and safety of the perioperative use of encorafenib, binimetinib, and cetuximab in patients with previously untreated surgical22
ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial canc22
Investigating the role of non-synonymous variant D67N of ADGRE2 in chronic myeloid leukemia21
A retrospective cohort study on radio/chemotherapy and survival following esophageal fistula in esophageal cancer patients with prior radiotherapy21
The significance and prognostic value of multifocal papillary thyroid carcinoma in children and adolescents21
Patient preferences for treatments in hormone receptor-positive/HER2-negative metastatic breast cancer in Italy: a discrete choice experiment study21
Nomogram based on autophagy related genes for predicting the survival in melanoma21
Melanoma risk, tumour stage, and melanoma-specific mortality in individuals with diabetes: a systematic review and meta-analysis21
Appropriate delay of primary tumour radiotherapy may lead to better long-term overall survival for non-small cell lung cancer treated with EGFR-TKIs21
A dosimetric comparison of brachytherapy sources for endometrial cancer: an electronic brachytherapy and an iridium-192 source with multichannel cylinders and a three-dimensional technique21
The epidemiology of haematological cancers in Sarawak, Malaysia (1996 to 2015)21
Activity and safety of KEES - an oral multi-drug chemo-hormonal metronomic combination regimen in metastatic castration-resistant prostate cancer21
A tool for predicting overall survival in patients with Ewing sarcoma: a multicenter retrospective study21
Prognostic significance of CD8 + tumor-infiltrating lymphocytes in operable breast cancer: a meta-analysis21
Rectal prolapse as an initial presentation of colorectal cancer: a systematic review21
The value of preoperative RDW for post-pancreatectomy haemorrhage and surgical prognosis in patients with pancreatic cancer: a retrospective study21
Establishment of potential lncRNA-related hub genes involved competitive endogenous RNA in lung adenocarcinoma21
Elevated miR-221-3p inhibits epithelial–mesenchymal transition and biochemical recurrence of prostate cancer via targeting KPNA2: an evidence-based and knowledge-guided strategy21
Trends in breast cancer mortality in Peru and its geographical areas from 2013 to 2022 and prediction until 202721
Identifying immunohistochemical biomarkers panel for non-small cell lung cancer in optimizing treatment and forecasting efficacy21
Detecting radiation esophagitis using 18F-FAPI-04 PET/CT in patients with LA-ESCC treated with concurrent chemoradiotherapy21
Barriers and facilitators to anal cancer screening among men who have sex with men: a systematic review with narrative synthesis21
The impact of financial burden on quality of life among German head and neck cancer survivors21
Different NGS identification methods of somatic mutation sites in solid tumors impact TMB results21
A predictive model for colorectal cancer complicated with intestinal obstruction based on specific inflammation score21
0.07232403755188